Neoplastic Cells, Circulating: all 244 studies

Page 3 of 3. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.

• Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture MethodCompletedNCT02025413Not applicable
• Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition BiologyWithdrawnNCT02022904Not applicable
• A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer RecurrenceStatus unknownNCT02005913
• Anesthesia and Circulating Tumor Cells in Breast CancerCompletedNCT02005770Phase 4
• Collection of Blood Specimens for Circulating Tumor Cell AnalysisCompletedNCT01943500
• Circulating Tumor Cells for Hepatocellular CarcinomaStatus unknownNCT01930383
• Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal CancerCompletedNCT01858805
• Circulating Tumor Cells (CTCs) in Advanced Gastric CancerStatus unknownNCT01848015
• Circulating Tumor Cells in Non-Small Cell Lung CarcinomaCompletedNCT01830426
• Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLCCompletedNCT01740804
• Detecting EGFR T790M Mutations From Circulating Tumor CellsCompletedNCT01734915
• Regional Anesthesia Versus General Anesthesia on Circulating Tumor Cells (CTC)CompletedNCT01716065
• Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal MetastasesCompletedNCT01713699Not applicable
• Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast CancersStatus unknownNCT01710605Phase 3
• Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy IndexCompletedNCT01701050
• Detection and Enumeration of Circulating Tumor Cells in Rectal CancerStatus unknownNCT01671891
• Circulating Tumor Cells in Lung CancerTerminatedNCT01658332Not applicable
• Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)CompletedNCT01640444Phase 2
• DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCsCompletedNCT01619111Phase 3
• COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal CancerCompletedNCT01596790Not applicable
• Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic MelanomaCompletedNCT01573494Not applicable
• Efficacy Study of Herceptin to Treat HER2-negative CTC Breast CancerCompletedNCT01548677Phase 2
• Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersCompletedNCT01528774
• Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyStatus unknownNCT01454037
• Circulating Tumor Cells in Prostate Cancer PatientsTerminatedNCT01414712
• Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast CancerCompletedNCT01322893
• Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast CarcinomaStatus unknownNCT01322750
• HER2 Circulating Tumor Cells in Gastric CancerCompletedNCT01299688
• Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor CellsTerminatedNCT01286883
• Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)CompletedNCT01173458
• Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell CarcinomaCompletedNCT01173445
• PET-CT and Circulating Tumor Cells in Colorectal CancerCompletedNCT01163305
• Effects of Chemotherapy on Circulating Tumor Cells and Recurrences in Cervical Cancer PatientsStatus unknownNCT01063296
• Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung CancerStatus unknownNCT01052818
• Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast CancerCompletedNCT01048918
• Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor CellsStatus unknownNCT01022723
• The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced DiseaseCompletedNCT00829920
• Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsTerminatedNCT00820924Phase 2
• Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer PatientsCompletedNCT00568282
• Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic AdenocarcinomaCompletedNCT00495924
• Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast CancerCompletedNCT00493350
• Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer PatientsCompletedNCT00351572
• Circulating Tumor Cells in Patients With Metastatic Colorectal CancerStatus unknownNCT00133913
• Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyStatus unknownNCT00133900

← Neoplastic Cells, Circulating overview